Lung Cancer

July 22, 2016July 22, 2016

1 in 12 in Cancer Patients Seen to Develop a Secondary Cancer in Long Term, Especially in Lungs

Lung Cancer, News

A study of long-term outcomes in cancer patients found that nearly 1 in every 12 go on to develop other, unrelated cancers, especially lung cancer. According to researchers at the University of California in Los ... Read more

July 20, 2016July 20, 2016

Researchers Discover New RNA Molecules Involved in Lung Cancer Development

Lung Cancer, News

A research team led by specialists at A*STAR’s Genome Institute of Singapore (GIS) is attempting to learn more about lung cancer, approaches to counteract and treat it, and how to give the ... Read more

July 18, 2016July 18, 2016

Enrollment for Metastatic Non-Small Cell Lung Cancer Trial Cleared by FDA

Lung Cancer, News

BeyondSpring Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) is allowing enrollment in the Phase 1/2 clinical trial to access the company’s drug plinabulin in combination with nivolumab for the treatment of metastatic ... Read more

July 15, 2016July 15, 2016

Center Enrolls First Lung Cancer Patient in Advanced Phase 3 Clinical Trial

Lung Cancer, News

For 40 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood by offering advanced technology, treatment and early detection. For residents of ... Read more

July 13, 2016July 13, 2016

Benefit of Portrazza on NSCLC Found to Be Minor and Limited to Metastatic Squamous Forms

Lung Cancer, News

An early benefit assessment indicated that while Portrazza (necitumumab) increases overall patient survival, additional negative effects reduce the impact of this outcome and result in only a minor added benefit for ... Read more

July 7, 2016July 7, 2016

$5M Grant Awarded to Maine Medical Center for Lung Cancer Prevention and Screening from BMS Foundation

Lung Cancer, News

The Bristol-Myers Squibb Foundation has given a $5 million grant to the Maine Medical Center for the creation of a statewide initiative to improve prevention, early detection, and treatment of lung cancer in the ... Read more

July 7, 2016July 7, 2016

Annual CT Scans as Good as Biopsies for Determining Cancer Risk of Lung Nodules, Study Says

Lung Cancer, News

Annual low-dose computed tomography (CT) scans are a good alternative to a biopsy or surgery for determining if nonsolid lung nodules (NSNs) are cancerous, researchers report. Their findings were published in the journal Radiology, in ... Read more

July 6, 2016July 6, 2016

Grant to Develop Diagnostic Tool for Non-Small Cell Lung Cancer Awarded to BioMarker Strategies

Lung Cancer, News

BioMarker Strategies was awarded a Phase 1/2 Fast Track Small Business Innovative Research grant from the National Cancer Institute (NCI) to develop a new biomarker test called PathMAP NSCLC. The diagnostic test will guide individualized ... Read more

July 5, 2016July 5, 2016

Lung Cancer Therapy Keytruda, Already OK’d for Different Cancers, Recommended for Approval in EU

Lung Cancer, News

Merck recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of the drug Keytruda (pembrolizumab), to be used ... Read more

June 13, 2016June 13, 2016

FDA Approves First Blood Test to Detect Specific Mutations in Non-Small Cell Lung Cancer

Lung Cancer, News

The U.S Food and Drug Administration (FDA) has approved the first blood-based genetic test designed to detect mutations in the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) ... Read more